序号 |
标题 |
次数 |
作者 |
发布时间 |
83791 |
CAS:753421-63-5 4-Aminobutyl-DOTA |
83 |
zyl |
2024-11-28 |
83792 |
Pteroyl-Lys-DOTA ,蝶酰-Lys-DOTA DOTA缀合的蝶酰-Lys衍生物 |
114 |
kx |
2024-11-28 |
83793 |
丙烯酸乙酯与丙烯酰胺接枝淀粉/β-环糊精树脂 EA-AM/β-CD |
102 |
h |
2024-11-28 |
83794 |
VIP-DOTA(靶向VPAC2-R) |
161 |
kx |
2024-11-28 |
83795 |
大环造影剂CAS:2126179-28-8;Ho-p-SCN-Bn-DOTA |
99 |
zyl |
2024-11-28 |
83796 |
Na[Gd(DOTA)·H2O]大环配合物 |
118 |
kx |
2024-11-28 |
83797 |
44Sc-DOTA-ZHER2:2891 , 亲和体分子ZHER2:2891偶联DOTA螯合剂 |
186 |
kx |
2024-11-28 |
83798 |
3,6-二胍基-1,2,4,5-四嗪高氯酸盐[DGTz·2(HClO4)] |
119 |
WYQ |
2024-11-28 |
83799 |
DOTA-三(酸) - 酰胺-DPEG(R)24-酰氨基-DPEG(R)24-DSPE |
92 |
zyl |
2024-11-28 |
83800 |
β-环糊精改性聚(氯甲基苯乙烯)树脂 β-CD/PS-Cl |
95 |
h |
2024-11-28 |
83801 |
3,6-二肼基-1,2,4,5-四嗪3,5-二硝基水杨酸盐二水合物(DHTz·DNSA-2H2O) |
150 |
WYQ |
2024-11-28 |
83802 |
DOTA-TOC,204318-14-9,依多曲肽 |
112 |
zcy |
2024-11-28 |
83803 |
DOTA-TRIS(TBE) - 酰胺基DPEG(R)11-马来酰亚胺 |
103 |
zyl |
2024-11-28 |
83804 |
β-环糊精改性机蒙脱七跟环氧树脂 E-44-β-CD |
167 |
h |
2024-11-28 |
83805 |
86Y-DOTA-Bn , 钇-86-DOTA-铃蟾肽 |
134 |
kx |
2024-11-28 |
83806 |
Gd-NOTA;钆-大环配体NOTA |
104 |
zcy |
2024-11-28 |
83807 |
3,6-二肼基-1,2,4,5-四嗪(DHTz) |
179 |
WYQ |
2024-11-28 |
83808 |
环糊精改性的脲醛树脂 CD-UF |
115 |
h |
2024-11-28 |
83809 |
CAS:177943-89-4 DOTATATE acetate |
157 |
zyl |
2024-11-28 |
83810 |
CAS:137076-54-1 三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
121 |
zyl |
2024-11-28 |
83811 |
3,6-双(1H-1,2,3,4-四唑-5-氨基)-1,2,4,5-四嗪(BTATz) |
101 |
WYQ |
2024-11-28 |
83812 |
3-甲基-5-芳基吡唑,3,4−e 并-1,2,3,4-四嗪衍生物 |
110 |
WYQ |
2024-11-28 |
83813 |
β-环糊精改性聚对二氧环己酮/聚乙烯醇水凝胶 β-CD-PPDO/PVA |
156 |
h |
2024-11-28 |
83814 |
DOTA-PAMAMG3.0-SH ,DOTA-PAMAMG3.0-巯基, DOTA偶联巯基化聚酰胺-胺(PAMAM)树形分子 |
118 |
kx |
2024-11-28 |
83815 |
3,3′-偶氮-1,2,4,5-四嗪衍生物 |
105 |
WYQ |
2024-11-28 |
83816 |
β-环糊精/Fe3O4/氧化石墨烯 |
121 |
h |
2024-11-28 |
83817 |
DOTA-PEG-CRGD环肽;大环配体DOTA-聚乙二醇-CRGD |
92 |
zcy |
2024-11-28 |
83818 |
3,6-二胍基-1,2,4,5-四嗪(DGTz) |
133 |
WYQ |
2024-11-28 |
83819 |
β-环糊精-聚丙烯酰胺水凝胶 β-CD-PAM |
162 |
h |
2024-11-28 |
83820 |
Iron DOTA Sodium Salt |
114 |
zyl |
2024-11-28 |
83821 |
环糊精-聚丙烯酸复合水凝胶 β-CD/PAA |
123 |
h |
2024-11-28 |
83822 |
3,6-二肼基-1,2,4,5-四嗪(DHTz) |
108 |
WYQ |
2024-11-28 |
83823 |
DOTA-c(RGDfK);具有特定生物活性的多肽分子 |
99 |
zcy |
2024-11-28 |
83824 |
1,2,3,4-四嗪-1,3-二氧化物 |
106 |
WYQ |
2024-11-28 |
83825 |
3,6-双(1H-1,2,4-三唑-3-氨基)-1,2,4,5-四嗪 |
99 |
WYQ |
2024-11-28 |
83826 |
3,6-双-(3,5-二氨基-1,2,4-三唑基)-1,2,4,5-四嗪(BTDTz) |
107 |
WYQ |
2024-11-28 |
83827 |
β-环糊精交联聚丙烯酸水凝胶 β-CD-6-A |
93 |
h |
2024-11-28 |
83828 |
DOTA-Tyr-3/temozolomide ,Dota-Tyr-3/替莫唑胺 |
94 |
kx |
2024-11-28 |
83829 |
3,6-二氯-1,2,4,5-四嗪(BCT) |
130 |
WYQ |
2024-11-28 |
83830 |
大豆多糖/β-环糊精三维纳米水凝胶 SSPS/β-CD |
131 |
h |
2024-11-28 |
83831 |
DOTA-3-酪氨酰基-奥曲肽,多肽化合物177943-89-4 |
91 |
zcy |
2024-11-28 |
83832 |
180978-54-5,DOTA-p-NH2-Bn-Biotin,DOTA-生物素-肌氨酸 |
102 |
zcy |
2024-11-28 |
83833 |
DOTA-Ala-Ala-Tyr-COOH;DOTA-丙氨酸-丙氨酸-酪氨酸-羧酸 |
101 |
zcy |
2024-11-28 |
83834 |
Ln-DOTA-Dimedone |
129 |
kx |
2024-11-28 |
83835 |
超亲水性/水下超疏油的纤维素/环糊精基聚电解质刷复合气凝胶 CE/β-CD-g-PDMAEMA |
188 |
h |
2024-11-28 |